Technical Flaws Prompt FDA to Weigh Extending Comment Deadlines

Drug Industry Daily
A A
The FDA may extend comment deadlines for certain drug-related regulations and guidance because the system through which online comments are submitted, Regulations.gov, was down for several days earlier this month.

To View This Article:

Login

Subscribe To Drug Industry Daily